| Application no. and date | 10730679.7 (espacenet) (Federated) (European Patent Register), 20100701 | | Patent/reg. no. and date | DK/EP 2448950, 20160113 | | Publication date | 20120509 | | Priority no. and date | US 270073 P, 20090702 | | EP pub. no. and date |
EP 2448950 20120509 | | Effective date | | | Applicant/owner | Rigel Pharmaceuticals, Inc., 1180 Veterans Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | Rigel 253.01 | | Inventor | FELFER, Ulfried, Gattermeyerweg 13
A-4040 Linz, AT,
GISELBRECHT, Karl-Heinz, Dr. Ignaz Semmelweis-strasse 3
A-4061 Langholzfeld, AT,
WOLBERG, Michael, Herbert-scholz-strasse 22
D-93073 Neutraubling, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07F 9/6561 (2006.01) | | Title | SYNTESE AF N4-(2,2-DIMETHYL-4-[(DIHYDROGENPHOSPHONOXY)-METHYL]-3-OXO-5-PYRIDO[1,4]OXAZIN-6-YL)-5-FLUOR-N2-(3,4,5-TRIMETHOXYPHENYL)-2,4-PYRIMIDINDIAMINDINATRIUMSALT | | Int. application no. | US2010040792 | | Int. publication no. | WO2011002999 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
